Drug Profile
Certoparin sodium - Novartis
Alternative Names: Certoparin; Mono-Embolex; Sandoparin; Sandoparine; TroparinLatest Information Update: 10 Sep 2020
Price :
$50
*
At a glance
- Originator Novartis
- Class Antithrombotics; Low molecular weight heparins
- Mechanism of Action Factor Xa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Deep vein thrombosis; Pulmonary embolism; Thromboembolism